Member Info for Rooba

Pl75 its not bleating - its frustration.

Its incompetent for AL not to understand the process and timelines between having the data and CE marking and he should stop building false expectations.

Yes, livenlearn. I've been one of biobank's guinea pigs for about 12 years, and its part of their studies.

I may or may not have missed if the dispute with the government over the antibody test has been resolved, but I received one of the AbC-19 tests today from UK biobank today. . . . . so they are definitely using them, and therefore need to pay for them!

Avacta's understanding and communication of expected timelines id fu**ing incompetent!

In Feb and March we were repeatedly told to expect CE mark and commercials by or around the end of March. These weren't long term predictions - A 3-week prediction on 8th March for CE marking is now into its 9th week. That's pathetic!

The target dates were bumped on in April to early May, which at a stretch is today at the very latest and still nothing.

Am I selling? No. This is a good investment with great potential. But please, FFS, stop building up our hopes and expectations on timescales, only to fail, and fail, and fail again!

Rant over!

I can be sceptical of companies that seem to over-promote themselves, but I have to say that so far Tirupati have delivered everything they promised, and more! I Couldn't be more impressed.

If they continue to grow as set out, the SP will do great.
If this composite they've developed comes off, and it is still an if, then the rewards will be huge.

So I've increased my stake here, as it feels like the returns will be somewhere between very good, ..... and brilliant!
GLA.

i just double-checked the 8th March RNS which predicted full CE marking around the end of March.
So We're now in week 8 of a 3 week prediction!
This investment is great overall, but AL's timeline expectations are appalling and so frustrating!

Richken sold most, if not all of his Avacta shares before the 100%+ rise this year, so it upsets him to post on here nowadays.

Poor Ken.

Until 2020, no expert ever saw lockdowns as the appropriate solution - they just didnt happen because they don't stop the endemic spread of a highly infectious virus.
With a few isolated exceptions, covid has spread across the world during multiple lockdowns, so lockdowns clearly haven't worked. They just alter the timeframe a bit (remember "flatten the curve").

I think in time these so-called experts will look back on 2020/21 on what NOT to do.

Given what we've been told about how specific affimers are, I think the 1% is probably a testing glitch and I bet AL is not happy with it. I just hope its not seen as a problem.

Agree that the AN swab method is a huge positive that is taken for granted in the update. But once better publicised, everybody would rather use one of these than a brain tickler.

Specificity 99% - could this be whats holding the SP back today?

Avacta actually met their target re AVA6000 target at the year end. Why? Because it was under their control.

The missed targets re the LFT have all been heavily, if not completely dependent on others.

I think we can trust Avacta to deliver, but not AL's misplaced/naive faith in others.

Thanks Paul.
I don't understand charting, but if its a tool that can predict a SP may go up or may go down, it sounds amazing!!

Where do i sign up for the course? ;-)

The ramping makes their treatment sound like the dogs b, but I honestly don't know. The greedy part of me wants it to be bull****, but if its a great step forward re cancer treatment, I'm not gonna complain about it.

Hi Hank, I didn't mention it because I didn't want to be accused of cross-ramping, but I noticed Hardy_aim and Richard Dutton ramping Portage (PRTG) on twitter, who are nearing phase 2 results for a similar approach to cancer treatment - ie. targeting the tumour.
I've not looked into the detail, (I'm v happy with my Avacta investments), so I don't know how much of a competitive threat it might be, but it served as a reminder not to take for granted other developments.

I would love Avacta to corner the market in this area, but I think we need to be realistic about the possibility of other / similar cancer treatments coming to market in the next year or 2, providing competition.
So, its okay to dream about some of those perfect scenario numbers, but foolish to expect them.

Lots of talk about the price on this board, when all that really matters (for investors) is the development of the science.
If that goes well, the price will look after itself.

I must be missing something - the fundamentals look good, the RNS looked very good (to me), profits increasing, outlook very good . . . . and share price falls!!

I know AIM investments often don't behave logically, so I'm hoping that's why the SP is falling and not that I am actually reading this all wrong.

A recent article I read talked about the pitfalls of emotional decisions based on fluctuating share prices and impatience. It cited a study where the most successful demographic of investors were dead!!

The fundamentals and future potential here are as good as when the SP rocketed.
The problem is, the SP went too high too quick and created unrealistic short term expectations.
Eqtec is a company going in the right direction and should hopefully climb back up again when news flows in - I think investors need some of that patience and fortitude that dead people have in abundance!!

Good luck all.

I read an interesting article this week describing one of the biggest problems for private investors as our own emotions, and over-reacting to share price movements, especially when the SP falls.
Often, buying and holding based on our initial research works best, and it quoted a study of an investment platform where the best performing demographic of investors were . . . . . . Dead!!!

If they deliver on their ambitions - and so far, so good - the growth will be huge.

Mining the minerals and taking them through fully integrated processes to deliver high quality products that are in huge and rapidly increasing demand will be massively profitable.

The strategy looks perfect and they seem in a hurry to achieve it. I’m holding long term here.

GLA.